Maze Therapeutics MAZE
NASDAQ MAZE
$32.44 +2.74 (+9.24%)
As of: Oct 20, 2026 · 3:59 PM EDT

Maze Therapeutics (MAZE) Operating Leases (2024 - 2026)

Updated

Maze Therapeutics' Operating Leases came in at $16.58 million for Q2 2026, down 18.3% from $20.29 million a year earlier and down 5.5% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, Maze Therapeutics' Operating Leases was $18.51 million, down 15.8% from FY2024.

  • Going back by year, Operating Leases was $22 million in FY2024.
  • Year-over-year, Operating Leases has declined for three consecutive quarters.
  • Business Quant data shows MAZE's Operating Leases at $17.55 million (Q1 2026), $18.51 million (Q4 2025) and $19.42 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Maze Therapeutics 1.91 Bn 417.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.58 Mn
Mar 31, 2026 17.55 Mn
Dec 31, 2025 18.51 Mn
Sep 30, 2025 19.42 Mn
Jun 30, 2025 20.29 Mn
Mar 31, 2025 21.15 Mn
Dec 31, 2024 22.00 Mn
API Access

Maze Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=MAZE&period=max&api_key=YOUR_API_KEY